Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Pharmacodynamic efficacy of second-generation intravitreal axitinib implant (Axpaxli™) in a VEGF challenge rabbit model

Charles Blizzard; Chintan Patel; MADHOOSUDAN PATIL; Erica Kahn; Joe Iacona; Daniel Domingues; Alyssa Whalen; Olivia Sherman; Mark Ransbottom; Dinesh Haswani; Rabia Gurses Ozden; Peter Jarrett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6520.

ARVO Annual Meeting Abstract June 2024

Optimized pharmacokinetic profile of intravitreal axitinib intravitreal implant (Axpaxli™): a comparison of first- and second-generation implants

MADHOOSUDAN PATIL; Chintan Patel; Erica Kahn; Joe Iacona; Daniel Domingues; Alyssa Whalen; Charles Blizzard; Olivia Sherman; Mark Ransbottom; Dinesh Haswani; Rabia Gurses Ozden; Peter Jarrett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1937.

ARVO Annual Meeting Abstract June 2024

Long-term safety of repeated intravitreal axitinib implant (Axpaxli™) administrations in non-human primates

Chintan Patel; MADHOOSUDAN PATIL; Erica Kahn; Joe Iacona; Daniel Domingues; Alyssa Whalen; Charles Blizzard; Olivia Sherman; Mark Ransbottom; Dinesh Haswani; Rabia Gurses Ozden; Peter Jarrett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1936.

ARVO Annual Meeting Abstract June 2023

Preclinical Safety and Tolerability of Repeated Intracameral Travoprost Implant (OTX-TIC) Administrations

Chintan Patel; Charles D Blizzard; Jeremy Hartman; Sean Serell; Kevin Yeh; Andrew Vanslette; Peter K Jarrett; Rabia Gurses Ozden

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4299.

ARVO Annual Meeting Abstract June 2022

A 6-Month GLP Toxicology Study of a Novel Hydrogel-based, Axitinib Intravitreal Implant (OTX-TKI) in Non-Human Primates

Chintan Patel; Erica Kahn; Megan Priem; Joe Iacona; Andrew Vanslette; Erik Wong; Charles D Blizzard; Peter K Jarrett; Michael Goldstein; Rabia Gurses-Ozden

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):298 – F0101.

ARVO Annual Meeting Abstract June 2022

A Safety and Pharmacokinetic Study of a Novel Hydrogel-based Axitinib Intravitreal Implant (OTX-TKI) in Non-Human Primates

Erica Kahn; Chintan Patel; Megan Priem; Joe Iacona; Andrew Vanslette; Erik Wong; Charles D Blizzard; Peter K Jarrett; Michael Goldstein; Rabia Gurses-Ozden

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):297 – F0100.

ARVO Annual Meeting Abstract June 2022

Safety and Pharmacodynamic Assessment of Repeated Intracameral Travoprost Implant Administration in Beagle Dogs

Charles D Blizzard; Chintan Patel; Jeremy Hartman; Sean Serell; Kevin Yeh; Andrew Vanslette; Peter K Jarrett; Michael Goldstein; Rabia Gurses-Ozden

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2852 – A0375.

ARVO Annual Meeting Abstract June 2022

Pharmacokinetics of a Hydrogel-based Nepafenac Intracanalicular Insert in Canines

Oktay Uzun; Ankita Desai; Sanjani Ray; Chintan Patel; Charles D Blizzard; Peter K Jarrett; Michael Goldstein

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):447.

ARVO Annual Meeting Abstract June 2022

Pharmacokinetics of a Hydrogel-based Besifloxacin Intracanalicular Insert in Canines

Megan Priem; Ankita Desai; Chintan Patel; Charles D Blizzard; Peter K Jarrett; Michael Goldstein

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2128 – F0144.

ARVO Annual Meeting Abstract June 2020

Inflammatory cytokine analysis of ocular fluids from a primate model of chronic vascular leakage and neovascularization

Chintan Patel; Donnicia James; Wenzheng Hu; Robin J Goody; Rahel Zulliger; Gabriella Widmer; Peter D Westenskow; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5395.

ARVO Annual Meeting Abstract July 2019

Multiphoton microscopy for three dimensional histology of retinal whole mounts

Chintan Patel; Rick Torres; Eben Olson; Michael Levene; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):183.

ARVO Annual Meeting Abstract July 2019

Quantification of fluorescein leakage induced by DL-2-aminoadipic acid in an experimental model of chronic neovascular leakage

Robin J Goody; Anish Kurian; Akeem Browne; Eleanor Demmons; Darnel Allen; Chintan Patel; Wenzheng Hu; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):200.

ARVO Annual Meeting Abstract July 2019

Targeting neurovascular injury: Arginase 1 promotes angiogenic repair and limits neurodegeneration

Ruth B Caldwell; Abdelrahman Y Fouda; Zhimin Xu; Jutamas Suwanpradid; Modesto Rojas; Esraa Shosha; Chintan Patel; Ji Xing; S. Priya Narayanan; Robert W. Caldwell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3258.

ARVO Annual Meeting Abstract July 2019

Characterization of DL-2-aminoadipic acid-induced histopathological changes in nonhuman primate retina

Shervin Liddie; Chintan Patel; Wenzheng Hu; Robin J Goody; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5993.

ARVO Annual Meeting Abstract July 2019

Optimization of trabecular meshwork laser strategy to achieve sustained 2-3X intraocular pressure elevation and glaucomatous optic neuropathy in primates

Wenzheng Hu; Chintan Patel; Jamila Martin; Vernard Woodley; Jordan Attwood; Tatiana Corey; Merissa O'connor; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):645.

ARVO Annual Meeting Abstract July 2018

A primate model of sustained retinal detachment

Chintan Patel; Jordan Attwood; Demetrios G. Vavvas; Matthew S Lawrence; David N. Zacks

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4243.

ARVO Annual Meeting Abstract July 2018

Persistent leaking in long term follow-up in the primate model of DL-2-aminoadipic acid-induced retinal neovascularization and vascular leakage

Wenzheng Hu; Donnicia James; Vernard Woodley; Chintan Patel; Anish Kurian; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5483.

ARVO Annual Meeting Abstract July 2018

Reproducibility and inter-animal variability of electroretinography measures in African green monkeys

Jordan D Attwood; Vernard Woodley; Chintan Patel; Anish Kurian; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5530.

ARVO Annual Meeting Abstract July 2018

Characterization of ocular anatomical and electrophysiological differences between young and geriatric African green monkeys

Shervin Liddie; Chintan Patel; Vernard Woodley; Jordan Attwood; Akeem Browne; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5847.

Retina May 2018

Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization

PDF

Hanfang Zhang; Farlyn Z. Hudson; Zhimin Xu; Rebekah Tritz; Modesto Rojas; Chintan Patel; Stephen B. Haigh; Zsuzsanna Bordán; David A. Ingram; David J. Fulton; Neal L. Weintraub; Ruth B. Caldwell; Brian K. Stansfield
TAGS: endothelial cells, neovascularization, pathologic, neurofibromatosis type 1 protein, retinal neovascularization, vascular endothelial growth factor a, mice, oxygen, hypoxia, proto-oncogene proteins c-akt, retinal diseases
Invest. Ophthalmol. Vis. Sci.. 2018; 59(6):2520-2528. https://doi.org/10.1167/iovs.17-22588

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Pharmacodynamic efficacy of second-generation intravitreal axitinib implant (Axpaxli™) in a VEGF challenge rabbit model

Optimized pharmacokinetic profile of intravitreal axitinib intravitreal implant (Axpaxli™): a comparison of first- and second-generation implants

Long-term safety of repeated intravitreal axitinib implant (Axpaxli™) administrations in non-human primates

Preclinical Safety and Tolerability of Repeated Intracameral Travoprost Implant (OTX-TIC) Administrations

A 6-Month GLP Toxicology Study of a Novel Hydrogel-based, Axitinib Intravitreal Implant (OTX-TKI) in Non-Human Primates

A Safety and Pharmacokinetic Study of a Novel Hydrogel-based Axitinib Intravitreal Implant (OTX-TKI) in Non-Human Primates

Safety and Pharmacodynamic Assessment of Repeated Intracameral Travoprost Implant Administration in Beagle Dogs

Pharmacokinetics of a Hydrogel-based Nepafenac Intracanalicular Insert in Canines

Pharmacokinetics of a Hydrogel-based Besifloxacin Intracanalicular Insert in Canines

Inflammatory cytokine analysis of ocular fluids from a primate model of chronic vascular leakage and neovascularization

Multiphoton microscopy for three dimensional histology of retinal whole mounts

Quantification of fluorescein leakage induced by DL-2-aminoadipic acid in an experimental model of chronic neovascular leakage

Targeting neurovascular injury: Arginase 1 promotes angiogenic repair and limits neurodegeneration

Characterization of DL-2-aminoadipic acid-induced histopathological changes in nonhuman primate retina

Optimization of trabecular meshwork laser strategy to achieve sustained 2-3X intraocular pressure elevation and glaucomatous optic neuropathy in primates

A primate model of sustained retinal detachment

Persistent leaking in long term follow-up in the primate model of DL-2-aminoadipic acid-induced retinal neovascularization and vascular leakage

Reproducibility and inter-animal variability of electroretinography measures in African green monkeys

Characterization of ocular anatomical and electrophysiological differences between young and geriatric African green monkeys

Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization

To View More...

You must be signed into an individual account to use this feature.